These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9037252)

  • 1. Human K562 transfectants expressing high levels of reduced folate carrier but exhibiting low transport activity.
    Wong SC; McQuade R; Proefke SA; Bhushan A; Matherly LH
    Biochem Pharmacol; 1997 Jan; 53(2):199-206. PubMed ID: 9037252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of lysine-411 in the human reduced folate carrier as an important determinant of substrate selectivity and carrier function by systematic site-directed mutagenesis.
    Witt TL; Matherly LH
    Biochim Biophys Acta; 2002 Dec; 1567(1-2):56-62. PubMed ID: 12488038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells.
    Wong SC; Proefke SA; Bhushan A; Matherly LH
    J Biol Chem; 1995 Jul; 270(29):17468-75. PubMed ID: 7615551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the E45K-reduced folate carrier gene mutation in methotrexate resistance in human leukemia cells.
    Gifford AJ; Haber M; Witt TL; Whetstine JR; Taub JW; Matherly LH; Norris MD
    Leukemia; 2002 Dec; 16(12):2379-87. PubMed ID: 12454742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional interactions between arginine-133 and aspartate-88 in the human reduced folate carrier: evidence for a charge-pair association.
    Liu XY; Matherly LH
    Biochem J; 2001 Sep; 358(Pt 2):511-6. PubMed ID: 11513752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of human reduced folate carrier gene expression by wild type p53.
    Ding BC; Whetstine JR; Witt TL; Schuetz JD; Matherly LH
    J Biol Chem; 2001 Mar; 276(12):8713-9. PubMed ID: 11106643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of a substrate binding domain of the human reduced folate carrier to transmembrane domain 11 by radioaffinity labeling and cysteine-substituted accessibility methods.
    Hou Z; Stapels SE; Haska CL; Matherly LH
    J Biol Chem; 2005 Oct; 280(43):36206-13. PubMed ID: 16115875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of high-level transport activity by human reduced folate carrier/ThTr1 thiamine transporter chimaeras: role of the transmembrane domain 6/7 linker region in reduced folate carrier function.
    Liu XY; Witt TL; Matherly LH
    Biochem J; 2003 Jan; 369(Pt 1):31-7. PubMed ID: 12227830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
    Spinella MJ; Brigle KE; Sierra EE; Goldman ID
    J Biol Chem; 1995 Apr; 270(14):7842-9. PubMed ID: 7713875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers.
    Whetstine JR; Gifford AJ; Witt T; Liu XY; Flatley RM; Norris M; Haber M; Taub JW; Ravindranath Y; Matherly LH
    Clin Cancer Res; 2001 Nov; 7(11):3416-22. PubMed ID: 11705857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport.
    Matherly LH; Czajkowski CA; Angeles SM
    Cancer Res; 1991 Jul; 51(13):3420-6. PubMed ID: 2054782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of transport activity by co-expression of human reduced folate carrier half-molecules in transport-impaired K562 cells: localization of a substrate binding domain to transmembrane domains 7-12.
    Witt TL; Stapels SE; Matherly LH
    J Biol Chem; 2004 Nov; 279(45):46755-63. PubMed ID: 15337749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination among reduced folates and methotrexate as transport substrates by a phenylalanine substitution for serine within the predicted eighth transmembrane domain of the reduced folate carrier.
    Zhao R; Gao F; Goldman ID
    Biochem Pharmacol; 1999 Nov; 58(10):1615-24. PubMed ID: 10535753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a human alternatively spliced truncated reduced folate carrier increasing folate accumulation in parental leukemia cells.
    Drori S; Sprecher H; Shemer G; Jansen G; Goldman ID; Assaraf YG
    Eur J Biochem; 2000 Feb; 267(3):690-702. PubMed ID: 10651805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH.
    Sierra EE; Brigle KE; Spinella MJ; Goldman ID
    Biochem Pharmacol; 1997 Jan; 53(2):223-31. PubMed ID: 9037255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary acute lymphoblastic leukemia cells use a novel promoter and 5'noncoding exon for the human reduced folate carrier that encodes a modified carrier translated from an upstream translational start.
    Flatley RM; Payton SG; Taub JW; Matherly LH
    Clin Cancer Res; 2004 Aug; 10(15):5111-22. PubMed ID: 15297414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a cysteine-less human reduced folate carrier: localization of a substrate-binding domain by cysteine-scanning mutagenesis and cysteine accessibility methods.
    Cao W; Matherly LH
    Biochem J; 2003 Aug; 374(Pt 1):27-36. PubMed ID: 12749765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transcriptional regulation of the human reduced folate carrier as a novel adaptive mechanism in response to folate excess or deficiency.
    Hou Z; Orr S; Matherly LH
    Biosci Rep; 2014 Aug; 34(4):. PubMed ID: 24949876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier.
    Wong SC; Zhang L; Witt TL; Proefke SA; Bhushan A; Matherly LH
    J Biol Chem; 1999 Apr; 274(15):10388-94. PubMed ID: 10187828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
    Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
    Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.